Donald Schwartz, PhD
|
Program:
Pharmacology
Graduated:
4/1999
Mentor:
Dr. John Lazo and Dr. Gregg Homanics
Thesis:
Bleomycin Hydrolase Knockout Mice: Creation and Phenotypic Evaluation.
Previous Institutions Attended:
Western Michigan University, BS in Biology
Wayne State University, MS in Biology
|
I am currently a Senior Scientist at Biodiscovery, LLC. My work involves the development, manufacture and testing of high density olionucleotide microarrays.
Recent Publications:
Schwartz DR, Kardia LR, Shedden KA, Kuick R, Michailidis G, Taylor JMG, Misek DE, Wu R, Zhai Y, Darrah D, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash S, and Cho K. (2002) Gene expression in ovarian cancer reflects both morphology and biologic behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 62:4722-29.
Schwartz* DR, Wu* R, Kardia SLR, Levin AM, Huang C-C, Shedden KA, Kuick R, Misek DE Hanash SM, Taylor JMG, Reed H, Hendrix N, Zhai Y, Fearon ER, and Cho KR. (2003) Novel candidate targets of ?-catenin/TCF signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. *equal contributors. Cancer Res 63:2913-22.
Publications while a graduate student at Pitt:
Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J Lazo, JS. (1999) The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc Natl Acad Sci USA 96:4680-85.
What did you enjoy most about your research experiences and graduate studies here at Pitt?
Personal attention and dedication from my mentors. In what ways did your training at Pitt prepare you for your current position?
The training gave me a strong foundation, which has allowed me to be successful in both academia and industry.
Back to Alumni Spotlight
|